Pathway to Cures

New York, United States
Pathway to Cures is focused on funding therapies for inheritable blood disorders.

About Pathway to Cures

Pathway to Cures is a Healthcare company based in New York (United States). Pathway to Cures is focused on funding therapies for inheritable blood disorders. It operates on a Donation / Grant-Based model. Pathway to Cures offers products and services including Venture Philanthropy Fund. Its focus areas include Biotechnology and Blood Disorder Therapies.

Company details

Pathway to Cures, under the National Bleeding Disorders Foundation, is dedicated to bridging funding gaps for the development of transformational therapies and technologies. Investments are made in companies innovating solutions for inheritable blood and bleeding disorders. The organization operates with a mission-oriented investment model to drive progress in the healthcare sector, specifically targeting advancements for affected communities.

  • Headquarters New York, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pathwaytocures.org
  • Social LinkedIn
Operational Areas

Products & Services of Pathway to Cures

Pathway to Cures offers a comprehensive portfolio of products and services, including Venture Philanthropy Fund.

Venture Philanthropy Fund
Investment

Funds are invested in blood disorder therapies development.

Top companies in Cell Therapy

3 companies that operate in the same segment as Pathway to Cures (Cell Therapy) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M520
CAR-T and TIL immunotherapies for solid tumors are developed.
2018San Francisco, California, United StatesUSD 493 MUSD 36 K233
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pathway to Cures

Pathway to Cures is headquartered in New York, United States. It is registered at New York, New York, United States.

Pathway to Cures, under the National Bleeding Disorders Foundation, is dedicated to bridging funding gaps for the development of transformational therapies and technologies. Investments are made in companies innovating solutions for inheritable blood and bleeding disorders. The organization operates with a mission-oriented investment model to drive progress in the healthcare sector, specifically targeting advancements for affected communities.

Pathway to Cures offers Venture Philanthropy Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available